D-0300-2015 Class II Terminated
FDA drug recall D-0300-2015 was initiated by American Health Packaging on Nov 19, 2014 and is designated Class II. Reason for recall: Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for… The recall status is terminated (terminated Jun 1, 2015). Affected quantity: 3496 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 24, 2014
- Initiation Date
- Nov 19, 2014
- Termination Date
- Jun 1, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3496 cartons
Product description
Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, Manufactured by Prometheus Laboratories Inc. 9410 Carroll Park Drive, San Diego, CA 92121, repackaged by American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217, NDC 68084-325-21
Reason for recall
Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.
Distribution pattern
Nationwide.
Code information
Lot #: 142450 Exp 05/2015; 140862 Exp 02/2015; 141596 Exp 03/2015; 134770 Exp 01/2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0300-2015
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026